HomeInsightsStock Comparison

Dishman Carbogen Amcis Ltd vs Indoco Remedies Ltd Stock Comparison

Dishman Carbogen Amcis Ltd vs Indoco Remedies Ltd Stock Comparison

Last Updated on: Jun 26, 2025

Key Highlights

  • The Latest Trading Price of Dishman Carbogen Amcis Ltd is ₹ 247.9 as of 26 Jun 10:17.
  • The P/E Ratio of Dishman Carbogen Amcis Ltd changed from 5.3 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Indoco Remedies Ltd changed from 79.9 on March 2020 to 30.8 on March 2024 . This represents a CAGR of -17.36% over 5 years.
  • The Market Cap of Dishman Carbogen Amcis Ltd changed from ₹ 840.79 crore on March 2020 to ₹ 3693 crore on March 2024 . This represents a CAGR of 34.45% over 5 yearsThe Market Cap of Indoco Remedies Ltd changed from ₹ 1929 crore on March 2020 to ₹ 3027 crore on March 2024 . This represents a CAGR of 9.43% over 5 years.
  • The revenue of Dishman Carbogen Amcis Ltd for the Mar '25 is ₹ 724.31 crore as compare to the Dec '24 revenue of ₹ 690.01 crore. This represent the growth of 4.97% The revenue of Indoco Remedies Ltd for the Mar '25 is ₹ 392.23 crore as compare to the Dec '24 revenue of ₹ 412.39 crore. This represent the decline of -4.89%.
  • The ebitda of Dishman Carbogen Amcis Ltd for the Mar '25 is ₹ 148.91 crore as compare to the Dec '24 ebitda of ₹ 147.8 crore. This represent the growth of 0.75% The ebitda of Indoco Remedies Ltd for the Mar '25 is ₹ 1.24 crore as compare to the Dec '24 ebitda of ₹ 13.87 crore. This represent the decline of -91.06%.
  • The net profit of Dishman Carbogen Amcis Ltd changed from ₹ 17 crore to ₹ 43.09 crore over 8 quarters. This represents a CAGR of 59.21% The net profit of Indoco Remedies Ltd changed from ₹ 24.18 crore to ₹ -41.34 crore over 8 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Dishman Carbogen Amcis Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Indoco Remedies Ltd changed from 11.4 % on March 2020 to 11.86 % on March 2024 . This represents a CAGR of 0.79% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Dishman Carbogen Amcis Ltd

  • Dishman Carbogen Amcis Limited was formerly incorporated as 'Carbogen Amcis (India) Limited' on July 17, 2007.
  • The Company name later on, was changed to 'Dishman Carbogen Amcis Limited' on 27 March 2017.
  • The Company is engaged in Contract Research and Manufacturing Services (CRAMS) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins & chemicals and disinfectants.
  • It works manufacturing and research facilities in India, Switzerland, France, The Netherland and China. During the financial year ended 31 March 2017, Dishman Pharmaceuticals and Chemicals Limited (DPCL) and Dishman Care Limited were merged with DPCL's subsidiary Carbogen Amcis (India) Limited, with the key objective of business consolidation and simplification of the Group structure.
  • The name of Carbogen Amcis (India) Ltd.

About Indoco Remedies Ltd

  • Indoco Remedies Limited, incorporated on August 23, 1947 is a Mumbai-based pharmaceutical company focused on formulations, with some presence in contract manufacturing and research.
  • The Company headquartered in Mumbai, is a fully integrated, research-oriented pharma Company with presence in 55 countries.
  • The Company is engaged in the manufacturing and marketing of pharmaceutical Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). Indoco, a USD 212 million company has 11 manufacturing facilities, 7 of which are for FDFs and 4 for APIs, supported by a state-of-the-art R&D Centre and a CRO facility. Currently, Indoco has a presence in therapeutic segments including anti-infective, anti-cold preparation, opthalmic, antispasmodic, stomatology, anti-inflammatory and anti-fungal.

Dishman Carbogen Amcis Ltd News Hub

News

Dishman Carbogen Amcis' Ahmedabad facility clears USFDA inspection without observations

The inspection was conducted from 9 June to 13 June 2025. According to the company's state...

Read more

16 Jun 2025 12:15

News

Carbogen Amic AG to co-invest in its manufacturing sites in Switzerland

Dishman Carbogen Amcis' wholly owned subsidiary, CARBOGEN AMCIS AG, a pharmaceutical proce...

Read more

06 Jun 2025 18:05

News

Dishman Carbogen spurts after turnaround Q4 outcome

Consolidated net sales rose 9.41% year-on-year to Rs 716.34 crore in Q4 March 2025. Pre-ta...

Read more

22 May 2025 12:16

News

Dishman Carbogen Amcis to hold board meeting

Dishman Carbogen Amcis will hold a meeting of the Board of Directors of the Company on 21 ...

Read more

17 May 2025 14:39

News

Dishman Carbogen Amcis' Shanghai facility clears China regulatory compliance

Dishman Carbogen Amcis announced that its Shanghai facility has successfully obtained its ...

Read more

21 Apr 2025 19:33

News

Dishman Carbogen Amcis receives affirmation in credit ratings

Dishman Carbogen Amcis has received affirmation in credit ratings from India Ratings and R...

Read more

16 Apr 2025 19:56

Indoco Remedies Ltd News Hub

News

Indoco Remedies gains after receiving USFDA nod for Allopurinol drug

Allopurinol is used to prevent or lower high uric acid levels in the blood. It is also use...

Read more

23 May 2025 11:34

News

Indoco Remedies receives USFDA final approval for Allopurinol Tablets

 Indoco Remedies announced final approval of Allopurinol Tablets USP, 200 mg through Compa...

Read more

23 May 2025 11:50

News

Board of Indoco Remedies recommends final dividend

Indoco Remedies announced that the Board of Directors of the Company at its meeting held o...

Read more

22 May 2025 21:09

News

Indoco Remedies to conduct board meeting

Indoco Remedies will hold a meeting of the Board of Directors of the Company on 22 May 202...

Read more

15 May 2025 15:46

News

Indoco Remedies Ltd leads losers in 'B' group

Premier Energies Ltd, Shiva Texyarn Ltd, Waaree Energies Ltd and Khandwala Securities Ltd ...

Read more

22 Jan 2025 14:45

News

Indoco Remedies slides on recording dismal Q3 numbers in FY25

Revenue from operations stood at Rs 364.91 crore in the third quarter of FY25, down 18.61%...

Read more

21 Jan 2025 12:53

SWOT Analysis Of Dishman Carbogen Amcis Ltd

Strength

1

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Indoco Remedies Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Dishman Carbogen Amcis Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Indoco Remedies Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Dishman Carbogen Amcis Ltd and Indoco Remedies Ltd

Which company has a larger market capitalization, Dishman Carbogen Amcis Ltd or Indoco Remedies Ltd?

Market cap of Dishman Carbogen Amcis Ltd is 3,905 Cr while Market cap of Indoco Remedies Ltd is 2,693 Cr

What are the key factors driving the stock performance of Dishman Carbogen Amcis Ltd and Indoco Remedies Ltd?

The stock performance of Dishman Carbogen Amcis Ltd and Indoco Remedies Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dishman Carbogen Amcis Ltd and Indoco Remedies Ltd?

As of June 26, 2025, the Dishman Carbogen Amcis Ltd stock price is INR ₹249.1. On the other hand, Indoco Remedies Ltd stock price is INR ₹292.0.

How do dividend payouts of Dishman Carbogen Amcis Ltd and Indoco Remedies Ltd compare?

To compare the dividend payouts of Dishman Carbogen Amcis Ltd and Indoco Remedies Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions